comparemela.com

Latest Breaking News On - Disc medicine - Page 2 : comparemela.com

Disc Medicine, Inc (NASDAQ:IRON) Receives Average Recommendation of Moderate Buy from Analysts

Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven brokerages that are presently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target price […]

Etrythropioetic protoporphyria kept man out of sun for 50 years, but experimental drug helps

Etrythropioetic protoporphyria kept man out of sun for 50 years, but experimental drug helps
abc.net.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abc.net.au Daily Mail and Mail on Sunday newspapers.

CRISPR Tx finds CMO in Sanofi leader—Chutes & Ladders

CRISPR Tx finds CMO in Sanofi leader—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

HC Wainwright Reiterates Buy Rating for Disc Medicine (NASDAQ:IRON)

HC Wainwright Reiterates Buy Rating for Disc Medicine (NASDAQ:IRON)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress

Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.